Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,828 | 72,881 | 64,081 | 52,135 | 53,587 |
| Marketable Securities | 1,495 | 1,495 | 1,495 | 1,325 | 1,325 |
| Receivables | 23,125 | 31,743 | 22,839 | 22,455 | 27,014 |
| Inventories | 82,332 | 88,052 | 106,017 | 79,047 | 69,916 |
| Income taxes - deferred | 19,533 | 16,096 | 16,096 | 16,096 | 16,096 |
| TOTAL | $197,996 | $215,180 | $214,227 | $177,290 | $172,971 |
| Non-Current Assets | |||||
| PPE Net | 138,289 | 134,112 | 133,991 | 118,565 | 116,619 |
| Other Non-Current Assets | 53,085 | 51,841 | 49,050 | 49,254 | 49,158 |
| TOTAL | $191,374 | $185,953 | $183,041 | $167,819 | $165,777 |
| Total Assets | $389,370 | $401,133 | $397,268 | $345,109 | $338,748 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,594 | 10,078 | 10,665 | 31,888 | 22,104 |
| Accounts payable and accrued liabilities | 10,161 | 10,013 | 17,764 | 17,571 | 20,380 |
| Accrued Expenses | 26,511 | 24,807 | 24,437 | 20,041 | 19,428 |
| TOTAL | $62,595 | $63,082 | $56,282 | $72,813 | $65,402 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,106 | 41,271 | 42,850 | 9,612 | 10,069 |
| Deferred Revenues | 14,013 | 14,596 | 643 | 643 | 643 |
| Other Non-Current Liabilities | 989 | 791 | 938 | 1,524 | 1,953 |
| TOTAL | $44,915 | $54,931 | $53,245 | $20,754 | $21,801 |
| Total Liabilities | $107,510 | $118,013 | $109,527 | $93,567 | $87,203 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,565 | 44,649 | 44,644 | 38,766 | N/A |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | 63,110 | 65,631 | 71,010 | 72,190 | 73,809 |
| Other shareholders' equity | -1,999 | -1,803 | -268 | 0 | 0 |
| TOTAL | $281,860 | $283,120 | $287,741 | $251,542 | $251,545 |
| Total Liabilities And Equity | $389,370 | $401,133 | $397,268 | $345,109 | $338,748 |